Lindbrook Capital’s PDL BioPharma, Inc. PDLI Stock Holding History

Lindbrook Capital’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,619	Closed	–	–	2052
2021 Q1	$0	Hold	1,619	–	–	﹤0.01%	1981
2020 Q4	$4K	Hold	1,619	–	–	﹤0.01%	1305
2020 Q3	$5K	Hold	1,619	–	–	﹤0.01%	1148
2020 Q2	$5K	Hold	1,619	–	–	﹤0.01%	1124
2020 Q1	$5K	Buy	+1,619	New	+$5.22K	﹤0.01%	1048

Other funds holding PDLI

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Lindbrook Capital's PDLI Position: Q2 2021 in Review

Lindbrook Capital sold out of PDL BioPharma, Inc. (PDLI) in Q2 2021, closing a stake of 1,619 shares.

Lindbrook Capital first reported a position in PDLI in Q1 2020 and held it in 5 quarters. The position peaked at $5K in Q3 2020. 8 funds tracked by Wall St. Rank hold PDLI as of Q2 2021.

Lindbrook Capital reported no remaining PDL BioPharma, Inc. position as of Q2 2021 after selling out during the quarter.
Lindbrook Capital sold 1,619 PDL BioPharma, Inc. shares in Q2 2021.
Lindbrook Capital first reported a position in PDL BioPharma, Inc. in Q1 2020 and held it in 5 quarters.
Lindbrook Capital's PDL BioPharma, Inc. position peaked at $5K in Q3 2020.
8 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2021.

Based on Lindbrook Capital's 13F filing for Q2 2021, filed 27 Jul 2021.